Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab

被引：0
|
作者：
Zaremba, A. [1 ]
Chorti, E. [1 ]
Jockenhoefer, F. [1 ]
Albrecht, M. [1 ]
Placke, J. M. [1 ]
Knispel, S. [1 ]
Schadendorf, D. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ]
Ugurel, S. [1 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P37
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    Ugurel, Selma
    Kiecker, Felix
    Froehling, Stefan
    Wetter, Axel
    Bankfalvi, Agnes
    Sucker, Antje
    Zimmer, Lisa
    Livingstone, Elisabeth
    Roesch, Alexander
    Becker, Juergen C.
    Schadendorf, Dirk
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 142 - 145
  • [22] COST EFFECTIVENESS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN ENGLAND
    Lee, D.
    Amadi, A.
    Sabater, J.
    Ellis, J.
    Johnson, H.
    Roskell, N.
    Meng, Y.
    Patterson, K.
    VALUE IN HEALTH, 2016, 19 (07) : A731 - A731
  • [23] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [24] Neoadjuvant Ipilimumab/Nivolumab combination in locally advanced or oligometastatic melanoma
    Ferrucci, Pier Francesco
    Lanfrancone, Luisa
    Mazzarella, Luca
    Nezi, Luigi
    Duso, Bruno Achutti
    Manzo, Teresa
    Lotti, Fiorenza
    Gandini, Sara
    Orsolini, Gianmarco
    Pennacchioli, Elisabetta
    Gnagnarella, Patrizia
    Fierro, Maria Teresa
    Senetta, Rebecca
    Riviello, Concetta
    Caliendo, Virginia
    Quaglino, Pietro
    Mazzarol, Giovanni
    Bonizzi, Giuseppina
    Cocorocchio, Emilia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (SUPPL 1)
  • [25] HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    Moshyk, A.
    Kotapati, S.
    VALUE IN HEALTH, 2019, 22 : S72 - S73
  • [26] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Potluri, Ravi
    Ranjan, Sandip
    Bhandari, Hitesh
    Johnson, Helen
    Moshyk, Andriy
    Kotapati, Srividya
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (1)
  • [27] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Ravi Potluri
    Sandip Ranjan
    Hitesh Bhandari
    Helen Johnson
    Andriy Moshyk
    Srividya Kotapati
    Experimental Hematology & Oncology, 8
  • [28] Nivolumab and Ipilimumab in Advanced Melanoma Reply
    Wolchok, Jedd D.
    Rollin, Linda
    Larkin, James
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2503 - 2504
  • [29] Tumor lysis syndrome associated with nivolumab plus ipilimumab combination therapy in a melanoma patient
    Magara, Azusa
    Kato, Hiroshi
    Oda, Takao
    Nakamura, Motoki
    Komatsu, Hirokazu
    Morita, Akimichi
    JOURNAL OF DERMATOLOGY, 2020, 47 (11): : E411 - E412
  • [30] Induction Exposure Dose of Ipilimumab and Failure of Adjuvant Nivolumab Plus Ipilimumab in Melanoma
    Augustin, Ryan C.
    Luke, Jason J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 443 - +
12345